이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

응급 의료 콜센터에서 소아 호흡 곤란 관리를위한 화상 회의 (VISIODYS-PED)

2026년 11월 4일 업데이트: Poitiers University Hospital

응급 의료 콜센터에서 소아 호흡 곤란 관리를위한 화상 회의 : Visiodys-Ped 무작위 통제 연구 프로토콜

Dyspnoea is defined as the sensation of difficult or uncomfortable breathing experienced by a patient. It is a significant concern in emergency care, accounting for 8% of calls to the emergency medical call centre (EMCC) and 10% of Emergency department (ED) admissions. Among paediatric patients, dyspnoea accounts from 14-27% of ED admissions, exhibiting notable seasonal variation. Approximately 10% of these patients require hospitalisation, and 1-3% of cases progress to respiratory failure. All these patients require a comprehensive clinical examination to accurately identify signs of severity, ensuring the timely initiation of specialized and effective treatment.

In France, patients are encouraged to contact the local EMCC before visiting an ED. Medical dispatchers assess the clinical condition by phone, based on medical history, symptoms and current treatment. Based on this assessment, the medical dispatcher determines the appropriate decision which may include providing medical advice, directing the patient to an ED, or deploying a mobile intensive care unit (MICU). Seven percent of calls to an EMCC involve paediatric cases, with nearly half concerning children under six years of age with hyperthermia and dyspnoea as most complaints, particularly during epidemic periods. The medical assessment of paediatric dyspnoea by EMCC is particularly challenging. The inability of children to articulate their symptoms, coupled with parents difficulty in describing the situation - often exacerbated by anxiety - creates significant obstacles. Furthermore, the absence of a direct observation by the physician adds to the complexity and could lead to an inappropriate triage and management.

Telemedicine uses communication technologies for remote consultations, electronic record management, and document sharing. It enables real-time visual evaluation, thereby improving diagnostic accuracy and decision-making. While evidence supports its benefits in managing adult dyspnoeic patients, further research is essential to validate its efficacy in paediatric settings, particularly within EMCC.

This study will aim to evaluate the effectiveness of telemedicine within an EMCC and utilising real-time visualization in reducing inappropriate triage of children requiring care for acute dyspnoea.

연구 개요

상태

완전한

정황

개입 / 치료

상세 설명

This is a superiority, prospective, individually randomized, open-label and monocentric study.

연구 유형

중재적

등록 (실제)

339

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • France
      • Poitiers, France, 프랑스, 86021
        • CHU Poitiers

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

3개월 (어린이)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Children aged between 3 months to 5 years
  • Call from parent(s) to an EMCC for dyspnea or shortness of breath or difficulty breathing as main complaint
  • Parent or witness with a phone/tablet equipped with a camera
  • Emergency consent or oral consent given by the holder(s) of parental authority to the physician dispatcher

Exclusion Criteria:

  • Child in life-saving emergency
  • Known absence of a telephone network required for the use of video calls
  • Call made by an individual who does not hold parental authority
  • Communication difficulties with the holder(s) of parental authority, not allowing for a clear and fair information
  • Person not benefiting from a social security scheme or through a third party
  • Child who has already participated in the study

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
간섭 없음: Standard medical dispatching process (Control group)

The emergency physician dispatcher conducts a standard medical dispatching process.

실험적: Addition of telemedicine to standard medical dispatching process (Experimental Group)

The emergency physician dispatcher conducts a standard medical dispatching process with the addition of telemedicine using video calls.

In the experimental group, the same approach is used, with the addition of telemedicine using video calls. Callers are invited to use their smartphone camera to enable real-time video assessment. The medical dispatcher sends a secure link (via a platform provided by Enovacom, Nomadeec, Bordeaux, France) to the caller's smartphone, allowing video streaming through a secure internet connection. Once the link is validated by the caller, the live video feed from the smartphone camera is transmitted directly to the dispatcher's computer screen, providing a visual evaluation to support clinical decision-making.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Proportion of patients inaccurately managed
기간: 24 hours

The primary endpoint is the proportion of patients inaccurately managed (over-triage or under-triage)

Over-triage is defined as a situation where a patient is:

  1. Directed to an ED following the call, but does not require any specific treatment, diagnostic tests, or hospitalisation, within 24h following the primary call, or
  2. Managed by the deployment of a MICU, despite not requiring specific treatment or transfer to an ED, within 24h following the primary call.

Under-triage is defined as a situation where a patient is kept at home with medical advice or directed to a family practitioner after the primary call AND later dispatched to hospital by a family practitioner or after a second call to an EMCC for dyspnoea, or hospitalised or dead within 24h following the primary call.

24 hours

2차 결과 측정

결과 측정
측정값 설명
기간
Proportion of patients who called a second time the emergency communication center for dyspnea
기간: 24 hours
24 hours
Proportion of deceased patients at day 28
기간: 28 days
28 days
Proportion of patients hospitalized within 28 days
기간: 28 days
28 days
Proportion of patients in over-triage situation
기간: 24 hours

Over-triage is defined as a situation where a patient is: (a) Directed to an ED following the call, but does not require any specific treatment, diagnostic tests, or hospitalisation, within 24h following the primary call, or (b) Managed by the deployment of a MICU, despite not requiring specific treatment or transfer to an ED, within 24h following the primary call.

24 hours
Proportion of patients in under-triage situation
기간: 24 hours

Under-triage is defined as a situation where a patient is kept at home with medical advice or directed to a family practitioner after the primary call AND later dispatched to hospital by a family practitioner or after a second call to an EMCC for dyspnoea, or hospitalised or dead within 24h following the primary call.

24 hours
Medical decision at the end of the call
기간: At the end of the call to emergency communication center

Proportion of patients in each situation at the end of the call: medical advice, referred to a non-hospital-based care, dispatched to an emergency department, emergency medical service.

At the end of the call to emergency communication center
Duration of the call
기간: At the end of the call

The duration of the call to emergency communication center, defined as the time between the beginning of the call and the medical decision (in minutes)

At the end of the call

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

수사관

  • 수석 연구원: Nicolas Marjanovic, MD PhD, Poitiers University Hospital
  • 수석 연구원: Erwan Ripley, MD, Poitiers University Hospital

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2025년 3월 30일

기본 완료 (실제)

2026년 7월 13일

연구 완료 (실제)

2026년 7월 13일

연구 등록 날짜

최초 제출

2025년 2월 21일

QC 기준을 충족하는 최초 제출

2025년 2월 21일

처음 게시됨 (실제)

2025년 2월 26일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 9일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 4일

마지막으로 확인됨

2026년 8월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • VISIODYS-PED

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

Desidentified participant data will be available from the corresponding author upon reasonable request, after approval of a proposal and signature of a data access agreement

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .